AVBP – arrivent biopharma, inc. (US:NASDAQ)
Stock Stats
News
ArriVent BioPharma (AVBP) had its "outperform" rating reaffirmed by Oppenheimer Holdings, Inc.. They now have a $50.00 price target on the stock, up from $44.00.
ArriVent BioPharma (AVBP) had its price target raised by Citigroup Inc. from $31.00 to $33.00. They now have a "buy" rating on the stock.
ArriVent BioPharma (AVBP) had its price target raised by HC Wainwright from $42.00 to $44.00. They now have a "buy" rating on the stock.
ArriVent BioPharma Reports Full Year 2025 Financial Results [Yahoo! Finance]
ArriVent BioPharma Reports Full Year 2025 Financial Results
Form S-8 ArriVent BioPharma, Inc.
Form 10-K ArriVent BioPharma, Inc. For: Dec 31
Form 8-K ArriVent BioPharma, Inc. For: Mar 05
Form SCHEDULE 13G/A ArriVent BioPharma, Inc. Filed by: Sofinnova Venture Partners IX, L.P.
Form SCHEDULE 13G/A ArriVent BioPharma, Inc. Filed by: INFINITUM ASSET MANAGEMENT, LLC
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.